Table 2. Summary of the obtained results.
| Cell line | EBV latency | Proteoglycans | HS biosynthetic enzymes | ECM molecules |
|---|---|---|---|---|
| primary B cells | - | serglycin, CD44 | EXT2, NDST2, 2OST1, 6OST1 | fibronectin, collagen1A1, elastin |
| CBM1-Ral-STO | III | serglycin, perlecan | NDST2, 6OST1 | fibronectin |
| CBC-JK2-STO | III | serglycin, perlecan | 6OST1 | fibronectin |
| Nad20 | III | serglycin, perlecan | 6OST1 | fibronectin |
| Mutu III cl.99 | II-III | perlecan | 2OST1 | - |
| Raji | II | perlecan | 2OST1, 3OST1, 6OST1 | - |
| Daudi | II | perlecan | 2OST1, 6OST1 | - |
| Akata | I | perlecan | 2OST1, 6OST1 | - |
| Rael | I | - | 2OST1 | - |
| Mutu I cl.148 | I | - | 2OST1 | - |
The genes with the highest relative expression levels are shown for each cell line. dash–gene(s) are expressed at very low level.